Celltrion to spend 75 bln won on share buyback

SEOUL, South Korean biopharmaceutical firm Celltrion Inc. said Tuesday it will spend around 75 billion won (US$56.2 million) to buy back its shares as part of efforts to increase its shareholders’ value.

The buyback of a total of 425,985 shares worth…

Read More »